Three new RSV vaccines and one new monoclonal antibody RSV treatment for infants have been approved by the FDA as we approach peak season for the virus.
Three new RSV vaccines and one new monoclonal antibody RSV treatment for infants have been approved by the FDA as we approach peak season for the virus.